Rapid molecular rifampicin-resistant tuberculosis (RR-TB) diagnosis (Xpert MTB/RIF or Ultra; Xpert) is increasingly decentralised in high TB burden countries. Pretreatment attrition after RR-TB diagnosis is not systematically reported as routine indicator by TB programmes, but leads to mortality and continued RR-TB transmission. RR-TB pretreatment attrition in high burden TB countries has not yet been quantified.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Tom
Contact Tom, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack